• Targeted mRNA Nanoparticles Repair the Poststroke BBB

  2026-09-20

  The ACS Nano study developed mannose-targeted lipid nanoparticles carrying IL-10 mRNA to redirect microglial responses in ischemic brain lesions. In mouse stroke models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and supported functional recovery, while illustrating both the promise and translational limits of targeted mRNA delivery.

• HyperScribe SP6 High Yield RNA Synthesis Kit Guide

  2026-09-19

  Build high-yield RNA transcripts for probes, translation, RNA interference experiments, and mechanistic studies of antiviral signaling. This workflow combines practical SP6 transcription guidance with assay choices inspired by the GADD34–IRF3 findings reported in SARS-CoV-2 research.

• JC-1 Mitochondrial Membrane Potential Assay Kit Guide

  2026-09-18

  The JC-1 Mitochondrial Membrane Potential Assay Kit converts mitochondrial depolarization into a practical red-to-green fluorescence readout for apoptosis assay design, mitochondrial function analysis, and natural-product screening. Applied to the aureonitol herbicide study, it offers a complementary way to test whether ROS-associated growth inhibition is accompanied by mitochondrial dysfunction.

• Protecting Lysosomal Repair Signals in Translation

  2026-09-18

  Lysosomal repair is a dynamic, protease-sensitive process that can be distorted during sample preparation. This thought-leadership article connects TECPR1-mediated membrane tubulation under energy stress with practical strategies for preserving protein complexes, phosphorylation-sensitive signals, and native structure. It explains how an EDTA-free formulation supports mechanistic studies without introducing unnecessary metal chelation, while offering protocol guidance, competitive positioning, translational cautions, and a forward-looking framework for connecting organelle biology with reproducible assay design.

• Cytochalasin D in Ocular Uptake Assays

  2026-09-17

  Cytochalasin D provides a mechanistic way to test whether actin-dependent processes contribute to nanoparticle uptake in corneal epithelial models. This article translates recent ocular delivery findings into practical assay controls while separating cytoskeletal effects from toxicity, cell-cycle changes, and nonspecific loss of cell function.

• miR-18a, ALOXE3, and Glioblastoma Progression

  2026-09-17

  The reference study identifies a miR-18a/ALOXE3 axis that links ferroptosis resistance, 12-HETE secretion, and glioblastoma cell migration. Its integrated genetic, biochemical, and orthotopic mouse experiments provide a framework for studying how lipid metabolism and GPCR-associated signaling jointly drive GBM progression.

• Pexidartinib: A Causal Tool for TAM Assays

  2026-09-16

  Pexidartinib (PLX3397) can serve as a mechanistic perturbation tool for dissecting CSF1R-dependent tumor-associated macrophage biology. This guide explains how to pair CSF1R inhibition with SPP1-focused assays to distinguish macrophage depletion, phenotypic remodeling, and direct anti-tumor effects.

• AST 487 in a KDM4A-Led Translational Strategy

  2026-09-16

  KDM4A is a compelling dependency in malignant pleural mesothelioma, but translating that biology requires more than a single inhibitor experiment. This article examines the evidence, proposes a decision-grade validation workflow, and positions AST 487 as a carefully bounded research reagent rather than an unproven substitute for direct KDM4A inhibition.

• RBMS1 Loss Enables PD-L1 Blockade in TNBC

  2026-09-15

  The reference study identifies the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer through control of PD-L1 stability. Its mechanistic link to B4GALT1 mRNA stability, PD-L1 glycosylation, and tumor-cell immune evasion provides a rationale for combining RBMS1 depletion with T-cell-based or checkpoint-directed therapies.

• Taltirelin Acetate: Research Workflows

  2026-09-15

  Taltirelin acetate connects TRHR1-centered neurobiology with practical Parkinson’s disease, itch, sleep, and formulation workflows. This guide translates published dissolution findings into assay design, dosing, controls, and troubleshooting decisions.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit Guide

  2026-09-14

  Build bright, reproducible RNA probes for in situ hybridization and Northern blot workflows while tuning Cy3-UTP incorporation to preserve transcription performance. This practical guide connects fluorescent probe design with mRNA-delivery research and provides executable setup, optimization, and troubleshooting strategies.

• Escitalopram Beyond the Product Page

  2026-09-14

  Escitalopram offers translational researchers a defined serotonergic reference point for connecting transporter pharmacology with antidepressant and anxiety-related outcomes. This article examines assay strategy, clinical interpretation, and the limits of extrapolating 5-HT reuptake inhibition into regimen-level efficacy.

• NAD+ Workflows for Stress-Response Assays

  2026-09-13

  Build more informative stress-adaptation experiments by pairing NAD+ redox measurements with caspase, PARP1, autophagy, and DNA-damage endpoints. This practical workflow distinguishes metabolic change from mechanistic evidence and provides starting conditions for cell-free, lysate-based, and breast cancer cell assays.

• Super-Enhancer–FOXA1–SLC7A11 Axis in Prostate Cancer

  2026-09-12

  The reference study defines a super-enhancer–FOXA1–SLC7A11 regulatory axis that links transcriptional control to disulfidptosis and prostate cancer progression. Its integrated genomic, epigenetic, pharmacological, and CRISPR-based design provides a framework for testing how nutrient stress reshapes cancer-cell vulnerability.

• TG003 Cdc2-like Kinase Inhibitor Workflows

  2026-09-11

  TG003 enables reversible control of Clk-dependent splicing, from splice site selection research to exon-skipping studies. Its broader Clk and CK1 activity also makes it a useful mechanistic probe for testing how CLK2-linked DNA repair may influence platinum response, provided target engagement and selectivity are carefully validated.

7858 records 1/524 page Next 12345 下5页 Last page